Pharos iBio

At a glance

Pharos iBio filed 25 disclosures in the last 12 months, including 2 insider, 2 5% holder and 1 issuance. The most recent key filing was on Jun 4.

The 2025 annual report lists 33 employees with an average tenure of 3.2 years and average pay of ₩62.7M. Its 5 directors and auditors were paid ₩144M each on average. It paid no cash dividend for 2025. 윤정혁 and related parties held 32.95% at year end.

From the 2025 annual report

Staff: 33 (18 men, 15 women), of whom 0 on fixed-term contracts. Total pay for the year: ₩2.1B. Directors and auditors: 5, paid ₩722M in total.

No cash dividend was paid for 2025.

Largest shareholder

윤정혁 holds 21.31%; with 12 related parties the group holds 32.95% of common shares at year end (from 32.78% at the start of the year).

Auditor: 삼도회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary